MMP-9/NGAL complex in oncocytoma was positive in 25% (1/4) of samples (range, 18–145; 80±52), and was positive in 44% (7/16) of ccRCC specimens (range, 14–306; 122±80). This evidence concerns the gene MMP9 and nonpapillary renal cell carcinoma.